ActiGraph Digital Data Summit Basel 2025
SEPTEMBER 12 | BASEL, Switzerland
Driving Adoption of Digital Measures in Clinical Research and Development
The ActiGraph Digital Data Summit (ADDS) brings together digital health leaders from across industry and academia to share real-world insights, scientific case studies, and best practices in the use of wearable technology for clinical research. Since 2022, ADDS has earned praise for its high quality scientific program and valuable networking opportunities—making it the perfect time to bring this event to Europe and connect with the region’s top digital health experts.
We're excited to announce that ADDS Basel 2025 will take place on September 12, 2025 at the
MC3 Main Conference Convention Center in Allschwil, Switzerland.
Be sure to check back regularly for new speakers and event updates!

Scientific Case Studies

Panel Discussions

Networking Forums

Poster Session

Featured Speakers

Eitan Asher, PhD
Data Scientist
Tel Aviv Sourasky Medical Center
Aiden Doherty, PhD
Professor of Biomedical Informatics
University of Oxford
Jonas Dorn, PhD
Digital Biomarker Tech Lead
Roche
Dawid Gerstel, PhD
Data Engineer
ActiGraph

Christine Guo, PhD
Chief Scientific Officer
ActiGraph
Dzmitry Kaliukhovich, PhD
Sr. Principal Data Scientist II
J&J Innovative Medicine
Mathieu Lemay, PhD
Signal Processing and AI Group
CSEM
Nikolay Manyakov, PhD
Senior Director, AI/Machine Learning and Digital Health
J&J Innovative Medicine
Michael Pettinati, PhD
Senior Data Scientist
ActiGraph

Sylvain Zorman, PhD
Director Digital Health Sciences
ActiGraph
Nathan Noakes
Sensor Solutions Director
Parexel
Dr. Jonathan Soslow
Associate Professor, Pediatric Cardiology Director of Clinical Research, Pediatric Cardiology Co-Director of the DMD Multispecialty Clinic
Vanderbilt University Medical Center
ADDS Basel 2025 Scientific Poster Session
We will host a scientific poster session during ADDS Basel featuring original research that involves the use of wearable digital health technologies (DHTs). This is an exciting opportunity for students and researchers to share their work with the broader digital health community. We invite you to submit your abstract for consideration no later than Sunday, July 27. Applicants are eligible to apply for a travel award based on scientific merit and financial need.
ADDS Basel 2025 Agenda - COMING SOON!
The ADDS Basel 2025 scientific program will consist of 4 focused sessions of presentations and panel discussions. Sessions on Neurology and Oncology will highlight new research findings using DHTs to advance R&D in these fields, and Technical Validation and Regulatory Pathways sessions will explore new opportunities and lessons learned, fostering discussion on how we can accelerate adoption of DHTs in regulated trials.
The detailed agenda will be published in the coming weeks - stay tuned for updates!
What Did Past Attendees Say About ADDS?
It's nice to have a conference that has a very specific focus, because we can dive much deeper into that and really get into the meat of the data. You can get into a much deeper understanding of the particular topic as well as some of the advancements in the field.
Ariel Dowling, PhD
Head of Sensing and Measurement | Takeda
It's a perfect thing when you can come to a conference, and you can meet people and immediately realize that you have things in common and can help each other; to meet other people who are really in different fields, but experiencing some of the same issues and develop potential collaborations across the board.
Johathan Soslow
Pediatric Cardiologist | Vanderbuilt University
An event like this brings talent that you normally are not exposed to, and as you see these presentations, you're shocked as to how much innovation is out there.
Peter Fernandes
CEO | Bellerophon Therapeutics
I think a lot of us do research in the technology and how we can apply it to our specific research interests or populations, but learning how to cross those boundaries between clinical populations is important.
Jennifer Schrack
Professor of Epidemiology and Medicine | Johns Hopkins Bloomberg School of Public Health



